NCT02233920 Post-marketing Surveillance of Ventilat® Metered Dose Inhaler in Chronic Obstructive Bronchitis Status COMPLETED Phase N/A
NCT02233907 Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT02233894 Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT02233881 Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT02233023 Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease Status COMPLETED Phase PHASE4
NCT02232594 Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease Status COMPLETED Phase N/A
NCT02232581 Study to Determine the Antiviral Activity and Safety of Alovudine in Nucleoside-experienced HIV-infected Subjects Experiencing Virologic Failure Status COMPLETED Phase PHASE2
NCT02232555 Study to Evaluate the Efficacy of Duloxetine in Outpatients With Major Depressive Disorder and Pain Status COMPLETED Phase PHASE3
NCT02232542 Tolerability and Safety of Duloxetine BID in Healthy Female Subjects Status COMPLETED Phase PHASE1
NCT02231931 Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin Status COMPLETED Phase PHASE1
NCT02231918 Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS) Status COMPLETED Phase PHASE2
NCT02231905 Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease Status COMPLETED Phase PHASE4
NCT02231437 Post-marketing Surveillance of Berodual® Metered-dose Inhaler in the Treatment of Chronic Obstructive Respiratory Tract Disease Status COMPLETED Phase N/A
NCT02231424 Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Airways Disease Status COMPLETED Phase N/A
NCT02231372 Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease Status COMPLETED Phase N/A
NCT02231359 Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease Status COMPLETED Phase N/A
NCT02231346 Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Comparison to a Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT02231320 Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT02231294 The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease Status COMPLETED Phase N/A